Cargando…

Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity

PURPOSE: To assess acute gastrointestinal (GI) and genitourinary (GU) toxicities of intensity-modulated proton therapy (IMPT) targeting the prostate/seminal vesicles and pelvic lymph nodes for prostate cancer. MATERIALS AND METHODS: A prospective study (ClinicalTrials.gov: NCT02874014), evaluating m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Richard, Hillman, David W., Daniels, Thomas, Vargas, Carlos, Rwigema, Jean Claude, Corbin, Kimberly, Keole, Sameer, Vora, Sujay, Merrell, Kenneth, Stish, Bradley, Pisansky, Thomas, Davis, Brian, Amundson, Adam, Wong, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489485/ https://www.ncbi.nlm.nih.gov/pubmed/34722810 http://dx.doi.org/10.14338/IJPT-20-00094.1

Ejemplares similares

Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
por: Laughlin, Brady S., et al.
Publicado: (2022)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Comparing bowel and urinary domains of patient‐reported quality of life at the end of and 3 months post radiotherapy between intensity‐modulated radiotherapy and proton beam therapy for clinically localized prostate cancer
por: Bai, Miao, et al.
Publicado: (2020)

Role of Pelvic Lymph Node Dissection in Prostate Cancer Treatment
por: Joung, Jae Young, et al.
Publicado: (2011)

Pelvic lymph node dissection in high-risk prostate cancer
por: Haiquel, Luciano, et al.
Publicado: (2021)

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT
por: Björeland, Ulrika, et al.
Publicado: (2018)

A narrative review of pelvic lymph node dissection in prostate cancer
por: Cheung, Douglas C., et al.
Publicado: (2020)

Impact of prostate focused alignment on planned pelvic lymph node dose
por: Kilian‐Meneghin, Joshua, et al.
Publicado: (2021)

Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021)

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison
por: Whitaker, Thomas J., et al.
Publicado: (2019)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
por: Osmonov, Daniar K., et al.
Publicado: (2014)

An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer
por: Groher, M., et al.
Publicado: (2017)

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
por: Gao, Robert W., et al.
Publicado: (2019)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

MRI-guided pelvic lymph node biopsy via transrectal approach in prostate cancer
por: Hague, Christian, et al.
Publicado: (2020)

Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
por: Jansen, B. H. E., et al.
Publicado: (2020)

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
por: Tsuchida, Keisuke, et al.
Publicado: (2020)

Impact of daily soft‐tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT
por: Tyagi, Neelam, et al.
Publicado: (2019)

Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection
por: Gottlieb, Josh, et al.
Publicado: (2023)

Pre-prostatic tissue removed in robotic assisted lymph node dissection for prostate cancer contains lymph nodes
por: Blarer, J., et al.
Publicado: (2013)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio B, et al.
Publicado: (2019)

Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection
por: Li, Zhen, et al.
Publicado: (2023)

Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes
por: Francesco, Porpiglia, et al.
Publicado: (2015)

Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma
por: Baker, Christopher B., et al.
Publicado: (2016)

Outcomes following external beam radiotherapy to the prostate and pelvic lymph nodes in addition to androgen deprivation therapy in non-metastatic prostate adenocarcinoma with regional lymph node involvement: a retrospective cohort study
por: Mohamad Roji, Akmal, et al.
Publicado: (2023)

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer
por: Ferreira, M.R., et al.
Publicado: (2019)

Prostate Cancer Metastatic to the Cervical Lymph Nodes
por: Sepúlveda, Luis, et al.
Publicado: (2015)

Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio Benito, et al.
Publicado: (2022)

Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer
por: Liu, Xiang, et al.
Publicado: (2022)

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
por: Dearnaley, David, et al.
Publicado: (2019)

Impact of prostatic anterior fat pads with lymph node staging in prostate cancer
por: Weng, Wei-Chun, et al.
Publicado: (2018)

Prostate specific antigen (PSA) persistence 6 weeks after radical prostatectomy and pelvic lymph node dissection as predictive factor of radiographic progression in node-positive prostate cancer patients
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Lymph node imaging in initial staging of prostate cancer: An overview and update
por: Zarzour, Jessica G, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1fh2hdm4nu8ges7654ukgnog80